Tag Archives: Cancer Treatment

New Treatment for Cancers Linked to BRCA Mutations

New Research for Breast Cancer Studies Genes
New Research for Cancer Studies Genes

Identification of Breast Cancer genetic mutations was a breakthrough for scientists working on cancer testing and treatment. Recent findings show that a new form of cancer treatment can effectively extend progression-free survival in patients with BRCA-related tumors.

PARP Inhibitors and BRCA-Related Cancers

PARP inhibitors make up a new class of cancer drugs that have been used primarily in a narrow application for women with ovarian and related forms of cancer. As presented at the European Society of Medical Oncology (ESMO) in Madrid last September, recent trial results open up possibilities of other uses.

The ARIEL-3 trial, sponsored by Clovis Oncology, involved 564 patients who received randomized doses of a placebo or Rubraca, a PARP inhibitor manufactured by Clovis. Rubraca was found to help women who had ovarian cancer both with and without BRCA mutations.

While Rubraca’s greatest effectiveness was in cases involving BRCA mutations, it also had a positive effect on some with other markers of impaired DNA repair. This condition is referred to as genomic scarring or BRCA-ness, related to a deficiency in homologous recombination repair (HRD).

Future Uses of PARP Inhibitors

Rubraca is currently approved in the U.S. for treatment of advanced BRCA-positive ovarian cancer. Based on the trial results, Clovis has applied for FDA approval of broader applications of Rubraca, including maintenance treatment. Researchers are hopeful that benefits will eventually extend to breast, pancreatic and prostate cancer.

Gene-Targeted Cancer Treatment Programs at Issels®

Gene-targeted therapies focus on blocking replication and growth of cancer cells, reducing risk to healthy cells. Contact us to learn more about cancer vaccines and other non-toxic cancer treatment programs at Issels®.

Cancer Patients – The Struggle to Understand Clinical Trial Opportunities

Cancer Patients Can Struggle to Understand if a Clinical Trial is Right for Them
Cancer Patients Can Struggle to Understand if a Clinical Trial is Right for Them

Clinical trials are essential for continued development of immunotherapy and other cancer treatment methods. A recent study shows that while cancer patients recognize the importance of clinical trials, they lack the same understanding about the concepts behind the process.

What Is the Public Conception of Clinical Trials?

Oncologist Catherine Kelly of Mater Misericordiae University Hospital in Dublin led a study involving 1,090 cancer patients being treated in centers across Ireland. Kelly presented the results at the September meeting of the European Society of Medical Oncology (ESMO) in Madrid.

Despite the fact that more than 25 percent of the subjects had previously participated in clinical trials, misunderstanding of central concepts was widespread throughout the responses.

  • Nearly three-quarters of those who had never taken part in a clinical trial didn’t understand that the types of treatment are randomly assigned. Surprisingly, this also applied to more than half of the patients who had participated in trials.
  • Most patients didn’t understand the concept of clinical equipoise, in which no one knows which of the treatments being tested is better. With previous clinical trial participants, an astonishing 60 percent believed that their doctor knew which treatment was better.

Why Understanding of Clinical Trials Matters

Results of this study were consistent with those from earlier studies. Kelly pointed out the need for doctors to address these misconceptions that instill fear in patients, preventing them from participating in trials.

Issels®: Cancer Treatment that Meets the Test of Time

At Issels®, our cancer vaccines and other immunotherapy treatments are not trials. Contact us to learn more about our long-standing success with individually tailored cancer treatment protocols.

What Can I Expect at the Issels Mexico In-Patient Hospital?

Do You Have Questions About What to Expect If You Come to Issels?
Do You Have Questions About What to Expect If You Come to Issels?

Cancer treatment is stressful and trying under the best of conditions. A first-class facility and caring staff can make a big difference in your peace of mind. Here’s an actual patient testimonial about her reassuring experience at our Issels® Mexico immunotherapy for cancer in-patient hospital.

“One Pleasant Surprise After Another”

Rita Possehl and her companion Teryl Springstead visited our Issels® Medical Center in Tijuana unsure of what to expect. The two were so satisfied with their experience that they wanted to share their recommendation with other potential patients.

“Caring and Considerate Staff”

One thing that immediately struck Rita and Teryl was the frequency of visits from staff members. The doctors stopped in at least once a day, and other staff members wore name tags and announced themselves each time they entered the room.

Ironically, it can sometimes be a challenge to get rest in a hospital room due to round-the-clock visits for vital sign checks. At Issels®, the checks begin around 8:00 AM and end around 10:00 PM so you can enjoy uninterrupted sleep.

“We Felt Pampered”

Rita and Teryl were impressed by how the staff worked to accommodate the wishes of both. For instance, the women were amazed to discover that Teryl’s dietary preferences were also honored along with Rita’s.

At the end of their stay, Rita and Teryl were pleased with the “warm, friendly staff” and “wholesome, delicious food” and recommended Issels® to other medical companions.

Quality Care at a Comfortable Location

Contact us to learn more about immunotherapy for cancer at our Issels® Medical Center in Tijuana, Mexico.

John McCain and Glioblastoma

It's Time to Stop Cancer
It’s Time to Stop Cancer

Two years ago, then-Vice President Joe Biden was inspired by the death of his son to launch a “moonshot” campaign for cancer treatment research. Today, Sen. John McCain’s battle against brain cancer has once again turned a spotlight on the disease.

Vice-President Biden Joins the Fight Against Cancer

In May 2015, Biden’s eldest son Beau succumbed to glioblastoma, an aggressive form of brain cancer. The same disease claimed the late Sen. Edward Kennedy in 2009.

Four months after his son’s death, Biden called off his expected run for the presidency in order to launch a campaign of a different sort. Biden and his advisors joined forces with the American Association for Cancer Research to ramp up the search for a cure.

Brain Cancer Remains in Public Awareness

Arizona Sen. John McCain, a one-time Presidential candidate himself, was diagnosed with glioblastoma this past July. The diagnosis added another layer of drama when McCain returned to Washington, D.C. a week later and cast the deciding vote against a proposed repeal of the Affordable Care Act.

Last month, McCain appeared on CNN’s State of the Union to discuss his illness. The senator told host Jake Tapper that he would be undergoing an MRI the following day, adding that advancements in cancer treatment gave hope for his prognosis.

State-of-the-Art Immunotherapy from Issels®

Researchers have been making astounding breakthroughs in cancer treatment. Issels® has long been a leader in the use of personally tailored immunotherapy programs to successfully treat patients with all forms of cancer.

Contact us for more information about our integrative, non-toxic treatments such as cancer vaccines and NK cells.

3-D Printing Allows Doctors to “Practice” Cancer Surgery

New Technology Helps to Train Doctors
New Technology Helps to Train Doctors

The classic med school model of practicing surgery on cadavers may soon be a thing of the past. Some doctors are now using 3-D printing models of patients’ organs as guides to improve outcomes of cancer treatment.

3-D Printing Improves Success of Prostate Cancer Treatment

While 3-D printing has been around since the mid-1980s, it’s just now coming into focus as a valuable tool for medical applications. One of the current pioneers of 3-D “surgery” is the USC Institute of Urology of Keck Medicine of USC.

Surgeons such as Dr. Inderbir Gill, executive director of the Institute, are using 3-D printed organs for patients with prostate cancer. The reproduction allows doctors to determine the precise location of tumors, which is virtually impossible to do during actual surgery.

Working with a 3-D model also helps surgeons reduce the risk of serious side effects that can occur during contact with areas surrounding the prostate. According to Dr. Gill, precision tools such as 3-D printing greatly improve the chances of completely removing the cancer.

Fine-Tuning Medication Dosage with 3-D Models

Another promising application of 3-D medical printing in cancer treatment involves the use of radiopharmaceuticals. Drugs containing radioactive material are administered to patients intravenously, orally, or placed inside a body cavity.

It’s challenging to determine a radiopharmaceutical dose that’s powerful enough to kill cancer cells without damaging healthy tissues as well. 3-D printing provides a vehicle to find the right balance.

Issels® Leads the Way in Non-Toxic Cancer Treatment

Our personally developed immunotherapy programs reduce the risk of harmful side effects found in traditional treatments. Contact us for more information.

Cancer News: Cancer Can Metastasize Without Involvement of the Lymph System

Metastatic cancer, where tumors spread from the original site to other parts of the body, presents a significant challenge for cancer treatment. Current research is causing scientists to rethink the conventional model of metastasis.

The Role of Lymph Nodes in Cancer Metastasis

A team of researchers led by Dr. Rakesh Jain of Massachusetts General Hospital studied 213 tissue samples from 17 patients diagnosed with colorectal cancer. The focus was on relationships between cells from the primary tumor, lymph nodes and remote sites of metastasis.

The scientists were surprised to discover that only 35 percent of the patients presented the traditional path of cancer moving via lymph nodes to more distant sites. In these cases, cancer cells from both metastases matched cell types in the original tumor.

In the other 65 percent of patients, both metastases matched different cells within the primary tumor, indicating separate origins. These results demonstrate that cancer may metastasize without involvement of lymph nodes, contradicting previously-held beliefs.

Applications for Future Cancer Treatment

According to Dr. Jain, lymph node metastases were generally considered forerunners of more distant metastases. Scientists were therefore puzzled why complete surgical removal of lymph nodes didn’t always improve survival rates.

Dr. Jain went on to explain that the typing assay his team developed can be a valuable way to analyze cancer’s path in certain patients. The information can then be used for better clinical management of metastatic cancer treatment.

Individualized Treatment for Patients at All Stages of Cancer

Issels® has an impressive track record of successfully treating cancer patients at all stages, including stage IV or metastatic cancer. Contact us for more information.